PHARMAC to fund more cancer medicines (March 2025)

12 March 2025 - PHARMAC is funding six more medicines for cancers and one for antibiotic resistant infections. ...

Read more →

PHARMAC consulting on widening access to venetoclax, azacitidine and upadacitinib monohydrate

16 January 2025 - PHARMAC is asking for feedback on a proposal to widen access to three medicines for five ...

Read more →

New Zealand Pharmaceutical Schedule - 1 January 2025

1 January 2025 - The January 2025 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

PHARMAC consulting on six medicines for New Zealanders

19 December 2024 - PHARMAC is asking for feedback on proposals to fund six medicines for cancer and antibiotic resistant ...

Read more →

PHARMAC funds more cancer and respiratory medicines for New Zealanders

6 December 2024 - More publicly funded medicines are on the way for people with types of breast and lung ...

Read more →

New Zealand Pharmaceutical Schedule - 1 December 2024

1 December 2024 - The December 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

Newly funded medicine to benefit 110 more people with thyroid, liver, and kidney cancer

8 November 2024 - PHARMAC has decided to fund lenvatinib from 1 December 2024 for people with some types of ...

Read more →

PHARMAC publishes agenda for the November 2024 PTAC meeting

 6 November 2024 - PHARMAC has published the agenda for the upcoming 14-15 November 2024 PTAC meeting. ...

Read more →

New Zealand Pharmaceutical Schedule - 1 November 2024

1 November 2024 - The November 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

10,000 New Zealanders set to benefit from PHARMAC budget increase

1 November 2024 - Thirteen new medicines funded from today will benefit thousands of New Zealanders with various health conditions ...

Read more →

PHARMAC improves access to three cancer medicines

10 October 2024 - PHARMAC will improve access to three cancer medicines from 1 November 2024. ...

Read more →

Rollout of new medicines across New Zealand begins

1 October 2024 - Today marks the first day a range of new medicines, including cancer medicines, will start to ...

Read more →

New Zealand Pharmaceutical Schedule - 1 October 2024

1 October 2024 - The October 2024 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...

Read more →

Proposal to fund medicines for lung cancer, breast cancer, and respiratory conditions

13 September 2024 - PHARMAC is seeking feedback on a proposal to fund four new medicines for cancer and respiratory ...

Read more →

First cancer medicine decision following PHARMAC funding boost

9 September 2024 - PHARMAC has decided to widen access to two medicines for several types of cancer. ...

Read more →